血液公司
US ˙ NYSE ˙ US4050241003

簡介

本頁面提供了有關 Charles J Dockendorff 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Charles J Dockendorff已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:HOLX / Hologic, Inc. Director 0
US:KEYS / Keysight Technologies, Inc. Director 55,213
US:HAE / Haemonetics Corporation Director 7,126
US:BSX / Boston Scientific Corporation Director 2,901
US:COV / EVP & Chief Financial Officer 0
如何解讀這些圖表

以下圖表顯示了在Charles J Dockendorff進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

HAE / Haemonetics Corporation內部人士買入 - 短期收益分析

在這一部分,我們分析了在 HAE / Haemonetics Corporation 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

HAE / Haemonetics Corporation Insider Trades
HAE / Haemonetics Corporation內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 HAE / Haemonetics Corporation 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2021-02-04 HAE Dockendorff Charles J 12,180 134.5300 12,180 134.5300 1,638,575 357 43.7700 -1,105,456 -67.46

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

HAE / Haemonetics Corporation Insider Trades
歷史內部人交易

該表格顯示了由 Charles J Dockendorff 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-04-09 2026-04-07 4 HOLX HOLOGIC INC
Common Stock
D - Sale to Issuer -15,370 0 -100.00
2026-04-09 2026-04-07 4 HOLX HOLOGIC INC
Common Stock
D - Sale to Issuer -6,626 0 -100.00
2026-03-24 2026-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 870 55,213 1.60
2026-03-02 2026-02-26 4 HOLX HOLOGIC INC
Common Stock
A - Award 3,190 6,626 92.84
2025-07-25 2025-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,693 7,126 60.75
2025-03-25 2025-03-21 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,589 54,343 3.01
2025-02-28 2025-02-26 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,864 3,436 118.58
2024-07-26 2024-07-25 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,207 4,433 99.15
2024-05-13 2024-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 2,901 2,901
2024-05-08 2024-05-07 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
S - Sale X -3,946 0 -100.00 72.70 -286,874
2024-03-26 2024-03-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,632 52,754 3.19
2024-03-11 2024-03-08 4 HOLX HOLOGIC INC
Common Stock
S - Sale X -1,465 1,572 -48.24 76.21 -111,648 119,802
2024-03-11 2024-03-07 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,572 3,037 107.30
2024-01-04 2024-01-02 4 HOLX HOLOGIC INC
Common Stock
S - Sale X -16,017 1,465 -91.62 72.00 -1,153,224 105,480
2024-01-04 2024-01-02 4 HOLX HOLOGIC INC
Common Stock
M - Exercise X 7,551 17,482 76.03 38.44 290,260 672,008
2023-09-07 2023-09-05 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10,215 2,226 -82.11 87.68 -895,651 195,176
2023-08-18 2023-08-18 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
S - Sale X -17,079 3,946 -81.23 50.74 -866,631 200,230
2023-08-08 2023-08-04 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,226 12,441 21.79
2023-05-05 2023-05-04 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 3,946 21,025 23.10
2023-05-05 2023-01-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
G - Gift -8,201 0 -100.00
2023-03-21 2023-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,543 51,122 3.11
2023-03-13 2023-03-09 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,465 6,725 27.85
2023-02-09 2023-02-07 4 HOLX HOLOGIC INC
Common Stock
G - Gift -1,336 0 -100.00
2023-01-10 2023-01-06 4 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -2,844 0 -100.00
2022-12-14 2022-12-13 4 KEYS Keysight Technologies, Inc.
Common Stock
S - Sale -3,257 52,423 -5.85 185.06 -602,753 9,701,682
2022-12-14 2022-12-12 4 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -7,551 55,680 -11.94
2022-08-08 2022-08-05 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,730 28,130 10.75
2022-05-09 2022-05-05 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,877 17,079 39.97
2022-03-22 2022-03-18 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,626 63,231 2.64
2022-03-14 2022-03-10 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,293 5,293
2022-03-14 2022-03-10 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,565 5,260 42.35
2021-12-07 2021-03-31 5 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -3,240 0 -100.00
2021-08-09 2021-08-06 4 HAE HAEMONETICS CORP
Common Stock
A - Award 3,077 25,400 13.78
2021-05-10 2021-05-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 2,439 39,501 6.58
2021-05-10 2021-05-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,763 37,062 14.75
2021-03-23 2021-03-19 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,631 64,845 2.58
2021-03-15 2021-03-11 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,055 5,055
2021-03-15 2021-03-11 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,478 3,695 66.67
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -12,180 0 -100.00
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -12,180 13,755 -46.96 134.53 -1,638,575 1,850,460
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 12,180 25,935 88.55 35.50 432,420 920,757
2020-07-22 2020-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,983 13,755 16.85
2020-05-11 2020-05-07 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 5,000 16,099 45.05
2020-03-23 2020-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,438 63,214 4.01
2020-03-09 2020-03-05 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7,322 7,322
2020-03-09 2020-03-05 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,217 22,129 11.13
2019-07-26 2019-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,460 20,340 7.73
2019-05-13 2019-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,990 11,099 81.68
2019-03-25 2019-03-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,351 60,776 4.02
2019-03-11 2019-03-07 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 6,523 6,523
2019-03-11 2019-03-07 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,136 19,912 12.02
2018-07-30 2018-07-26 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,696 18,880 9.87
2018-05-11 2018-05-10 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 6,109 63,213 10.70
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 3,897 58,425 7.15
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 780 54,528 1.45
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,949 53,749 3.76
2018-03-16 2018-03-15 4 HOLX HOLOGIC INC
Common Stock
P - Purchase 13,000 17,776 272.19 38.80 504,400 689,709
2018-03-16 2018-03-14 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7,551 7,551
2018-03-16 2018-03-14 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,406 4,776 101.52
2017-07-31 2017-07-27 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,329 17,184 33.68 39.27 170,000 674,816
2017-06-13 2017-06-09 4 KEYS Keysight Technologies, Inc.
Common Stock
P - Purchase 13,210 51,800 34.23 37.81 499,470 1,958,554
2017-05-16 2017-05-15 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,396 5,396
2017-05-16 2017-05-15 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,747 2,370 280.42
2017-05-16 3 HOLX HOLOGIC INC
Common Stock
1,246
2017-05-16 3 HOLX HOLOGIC INC
Common Stock
1,246
2017-05-11 2017-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 7,012 57,104 14.00
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 4,720 38,590 13.94 39.02 184,174 1,505,778
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 656 33,870 1.97 39.02 25,584 1,321,604
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,360 33,214 7.65 39.02 92,101 1,296,020
2016-05-04 2016-05-03 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 8,494 50,092 20.42
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 962 30,844 3.22 25.98 25,000 801,325
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 3,464 29,882 13.11 25.98 90,000 776,325
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 6,928 26,417 35.55 25.98 179,989 686,325
2016-02-16 2016-02-12 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
P - Purchase 30,000 41,598 258.67 16.49 494,688 685,934
2015-11-09 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 656 19,489 3.48 38.74 25,405 755,020
2015-11-09 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,397 18,834 14.58 38.74 92,852 729,615
2015-11-09 2015-01-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,122 16,437 7.33 35.78 40,140 588,110
2015-07-23 2015-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,337 7,153 154.01
2015-05-07 2015-05-05 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 10,650 11,598 1,123.42
2015-05-04 2015-05-01 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 948 948
2015-03-23 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 4,793 15,315 45.55
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -78,769 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -65,095 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -103,051 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -132,583 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -107,632 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -88,753 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -107,179 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -3,776 107,179 -3.40
2015-01-26 2015-01-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,756 10,522 20.03
2014-12-04 2014-12-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,061 47,278 -2.19 102.36 -108,604 4,839,376
2014-12-03 2014-12-02 4 COV Covidien plc
Ordinary Shares
F - Taxes -812 48,339 -1.65 101.61 -82,507 4,911,726
2014-12-03 2014-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -3,342 49,151 -6.37 100.99 -337,509 4,963,759
2014-12-03 2014-12-01 4 COV Covidien plc
Ordinary Shares
A - Award 3,763 52,493 7.72
2014-11-07 2014-11-05 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 8,766 8,766
2014-10-07 2014-10-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -22,418 48,638 -31.55 93.89 -2,104,826 4,566,622
2014-10-07 2014-10-03 4 COV Covidien plc
Ordinary Shares
A - Award 47,490 71,056 201.52
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 12,180 12,180
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,816 2,816
2014-07-25 3 HAE HAEMONETICS CORP
Common Stock
5,632
2014-07-25 3 HAE HAEMONETICS CORP
Common Stock
5,632
2014-03-28 2014-03-28 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -90,730 0 -100.00
2014-03-28 2014-03-28 4 COV Covidien plc
Ordinary Shares
S - Sale X -90,730 112,131 -44.73 72.50 -6,577,925 8,129,498
2014-03-28 2014-03-28 4 COV Covidien plc
Ordinary Shares
M - Exercise 90,730 202,861 80.91 39.32 3,567,504 7,976,495
2014-02-24 2014-02-20 4 COV Covidien plc
Ordinary Shares
A - Award 104 112,131 0.09 71.28 7,413 7,992,698
2014-01-10 2014-01-10 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -90,000 90,730 -49.80
2014-01-10 2014-01-10 4 COV Covidien plc
Ordinary Shares
S - Sale X -90,000 112,027 -44.55 69.50 -6,255,000 7,785,876
2014-01-10 2014-01-10 4 COV Covidien plc
Ordinary Shares
M - Exercise 90,000 202,027 80.34 39.32 3,538,800 7,943,702
2013-12-12 2013-12-02 4/A COV Covidien plc
Ordinary Shares
A - Award 6,757 113,071 6.36
2013-12-04 2013-12-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,044 170,365 -0.61 67.24 -70,199 11,455,343
2013-12-04 2013-12-02 4 COV Covidien plc
Stock Option (Right to Buy)
A - Award 6,757 6,757
2013-12-04 2013-12-02 4 COV Covidien plc
Ordinary Shares
A - Award 65,095 171,409 61.23
2013-12-04 2013-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -4,959 106,314 -4.46 68.26 -338,501 7,256,994
2013-11-15 2013-11-15 4 COV Covidien plc
Ordinary Shares
S - Sale -39,397 111,273 -26.15 66.22 -2,609,023 7,368,932
2013-11-07 2013-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 146 150,670 0.10 64.33 9,392 9,692,601
2013-09-30 2013-09-27 4 COV Covidien plc
Ordinary Shares
F - Taxes -15,144 150,524 -9.14 60.96 -923,178 9,175,943
2013-09-30 2013-09-27 4 COV Covidien plc
Ordinary Shares
A - Award 32,080 165,668 24.01
2013-08-16 2013-08-15 4 COV Covidien plc
Ordinary Shares
A - Award 119 133,588 0.09 61.85 7,360 8,262,418
2013-08-16 2012-12-21 4 COV Covidien plc
Ordinary Shares
G - Gift -4,350 131,103 -3.21
2013-08-08 2013-08-08 4 COV Covidien plc
Ordinary Shares
S - Sale -391 137,819 -0.28 63.71 -24,911 8,780,448
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -31,816 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -27,409 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -35,572 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
S - Sale -94,797 138,210 -40.68 63.15 -5,986,269 8,727,727
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 27,409 233,007 13.33 33.76 925,328 7,866,316
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 31,816 205,598 18.31 31.16 991,387 6,406,434
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 35,572 173,782 25.74 41.66 1,481,930 7,239,758
2013-05-07 2013-05-03 4 COV Covidien plc
Ordinary Shares
A - Award 105 135,677 0.08 64.35 6,757 8,730,815
2013-02-12 2013-02-11 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -32,457 0 -100.00
2013-02-12 2013-02-11 4 COV Covidien plc
Ordinary Shares
S - Sale -32,457 135,572 -19.32 63.31 -2,054,905 8,583,280
2013-02-12 2013-02-11 4 COV Covidien plc
Ordinary Shares
M - Exercise 32,457 168,029 23.94 35.45 1,150,708 5,957,183
2012-12-28 2012-12-27 4 COV Covidien plc
Ordinary Shares
A - Award 119 135,572 0.09 57.35 6,825 7,775,054
2012-12-04 2012-12-03 4 COV Covidien plc
Stock Option (Right to Buy)
A - Award 71,870 71,870
2012-12-04 2012-12-03 4 COV Covidien plc
Ordinary Shares
A - Award 7,921 135,453 6.21
2012-12-04 2012-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -5,818 127,532 -4.36 58.11 -338,084 7,410,885
2012-11-26 2012-11-23 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -87,090 29,030 -75.00
2012-11-26 2012-11-23 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -47,039 0 -100.00
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
S - Sale -134,129 133,350 -50.15 57.00 -7,645,353 7,600,950
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
M - Exercise 47,039 267,479 21.34 38.65 1,817,987 10,337,662
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
M - Exercise 87,090 220,440 65.31 34.15 2,974,124 7,528,026
2012-11-07 2012-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 148 133,350 0.11 55.65 8,236 7,420,928
2012-10-09 2012-10-04 4 COV Covidien plc
Ordinary Shares
F - Taxes -10,564 133,202 -7.35 60.16 -635,530 8,013,432
2012-10-09 2012-10-04 4 COV Covidien plc
Ordinary Shares
A - Award 25,300 143,766 21.36
2012-08-20 2012-08-16 4 COV Covidien plc
Ordinary Shares
A - Award 126 118,466 0.11 57.59 7,256 6,822,457
2012-05-09 2012-05-07 4 COV Covidien plc
Ordinary Shares
A - Award 131 118,340 0.11 54.25 7,107 6,419,945
2012-02-24 2012-02-22 4 COV Covidien plc
Ordinary Shares
A - Award 136 118,209 0.12 52.45 7,133 6,200,062
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)